REFERENCES
- Ward MK, Fraser TR. DDAVP in treatment of vasopressin-sensitive diabetes insipidus. Br Med J 1974; 3: 86–9.
- Matthiesen TB, Rittig S, Djurhuus JC, Norgaard JP. A dose titration, and an open 6-week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. J Urol 1994; 151: 460–3.
- Hilton P, Stanton SL. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol 1982; 54: 252–5.
- Kinn AC, Larsson PO. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol 1990; 24: 109–12.
- Hilton P, Hertogs K, Stanton SL. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatr 1983; 46: 854–5.
- Rew DA, Rundle JS. Assessment of the safety of regular DDAVP therapy in primary nocturnal enuresis. Br J Urol 1989; 63: 352–3.
- Valiquette G, Abrams GM, Herbert J. DDAVP in the management of nocturia in multiple sclerosis (letter). Ann Neural 1992; 31: 577.
- Ferrie BG, MacFarlane J, Glen ES. DDAVP in young enuretic patients: a double-blind trial. Br J Urol 1984; 56: 376–8.
- Knoll M, Madersbacher H. Are plasma-AVP levels of predictive value for the therapeutic effect of desmopressin (DDAVP) in nocturnal enuresis? J Urol 1991; 145: 302A.
- Norgaard JP, Jonler M, Riis-Jorgensen JC, Christensen S, Rittig S, Djurhuus JC. Pharmacokinetics of DDAVP in treatment of nocturnal enuresis. J Urol 1990; 143: 218A.
- Chancellor MB, Hirsch IH, Kiilholma PJ. DDAVP in the management of nocturia in multiple sclerosis. 1991 Annual Meeting of the Mid-Atlantic Section of the American Urological Association.
- Chancellor MB, Rivas DA. DDAVP in the symptomatic management of voiding symptoms in men with benign prostatic hyperplasia. J Urol 1994; 151: 507A.